HomeLTRN • NASDAQ
add
Lantern Pharma Inc
Previous close
$3.77
Day range
$3.62 - $3.90
Year range
$2.56 - $6.12
Market cap
41.94M USD
Avg Volume
97.57K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.35M | -16.02% |
Net income | -4.18M | 7.29% |
Net profit margin | — | — |
Earnings per share | -0.39 | — |
EBITDA | -4.35M | 16.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.36M | -55.93% |
Total assets | 13.63M | -55.02% |
Total liabilities | 4.04M | 9.33% |
Total equity | 9.59M | — |
Shares outstanding | 11.18M | — |
Price to book | 4.33 | — |
Return on assets | -70.05% | — |
Return on capital | -97.32% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -4.18M | 7.29% |
Cash from operations | -4.57M | 18.10% |
Cash from investing | 5.93M | 771.40% |
Cash from financing | 971.78K | 8,002.23% |
Net change in cash | 2.33M | 147.77% |
Free cash flow | -3.13M | 20.37% |
About
Founded
2013
Headquarters
Website
Employees
24
